Brief: Phasebio Announces Successful Pre-BLA Meeting With U.S. FDA For Bentracimab

PhaseBio Pharmaceuticals

16/05/2022 11:02

May 16 (Reuters) - PhaseBio Pharmaceuticals Inc  PHAS.O :
    * PHASEBIO ANNOUNCES SUCCESSFUL PRE-BLA MEETING WITH U.S. FDA FOR
BENTRACIMAB
    * PHASEBIO PHARMACEUTICALS INC - EXPECTING TO SUBMIT ITS BIOLOGICS LICENSE
APPLICATION (BLA) FOR BENTRACIMAB BY EARLY IN Q4 OF 2022
    * PHASEBIO PHARMACEUTICALS INC - FDA INDICATED WILLINGNESS TO ACCEPT A BLA
FOR
BENTRACIMAB WITH DATA FROM 25-30 UNCONTROLLED BLEEDING PATIENTS

Source text for Eikon:  ID:nBw5B1GJfa 
Further company coverage:  PHAS.O 

 ((Reuters.Briefs@thomsonreuters.com;))